Headlines:
Tag: Present
Caveonix CEO Kaus Phaltankar to Present "Best Practices: Security and Compliance for Cloud Workloads" with IBM at VMworld 2019 Europe

Caveonix CEO Kaus Phaltankar to Present "Best Practices: Security and Compliance for Cloud Workloads" with IBM at VMworld 2019 Europe

November 1, 2019 Economie

FALLS CHURCH, Virginia, Nov. 1, 2019 /PRNewswire/ -- Caveonix , the company automating compliance and security posture management for the hybrid and multi-cloud, today ...

Lees verder
Ovid Therapeutics to Present at the 12th International Epilepsy Colloquium

Ovid Therapeutics to Present at the 12th International Epilepsy Colloquium

May 24, 2019 Economie

First scientific presentation of OV-935 (TAK-935) safety and tolerability data in developmental and epileptic encephalopathies from the Phase 1b/2a clinical trial Study met ...

Lees verder
SuperTurbo Technologies To Present At SAE World Congress With Isuzu Motors

SuperTurbo Technologies To Present At SAE World Congress With Isuzu Motors

April 4, 2019 Economie

LOVELAND, Colorado, April 3, 2019 /PRNewswire/ -- SuperTurbo Technologies Inc. announced it will be presenting a paper at SAE World Congress with Isuzu Motors titled ...

Lees verder
Norgine and Its Partner Salix Present New Data From PLENVU® (NER1006) Phase 3 Studies at Digestive Disease Week (DDW) 2018

Norgine and Its Partner Salix Present New Data From PLENVU® (NER1006) Phase 3 Studies at Digestive Disease Week (DDW) 2018

June 5, 2018 Economie

AMSTERDAM, June 5, 2018 /PRNewswire/ -- Norgine B.V. today with its partner Salix Pharmaceuticals, Ltd. ("Salix"), announced that they will present new data from phase 3 ...

Lees verder
Menarini Ricerche to Present the Study Design of CD205-Shuttle, a First-in-human Trial of MEN1309/OBT076, at the ASCO Annual Meeting 2018

Menarini Ricerche to Present the Study Design of CD205-Shuttle, a First-in-human Trial of MEN1309/OBT076, at the ASCO Annual Meeting 2018

June 2, 2018 Economie

POMEZIA, Italy, June 1, 2018 /PRNewswire/ -- Menarini Ricerche (Menarini Group) will present at ASCO Annual Meeting 2018 the study design of CD205-Shuttle, a multicenter ...

Lees verder
Menarini Ricerche to Present the Most Recent Pre-clinical Data About the PI3K Inhibitor MEN1611 at the AACR Annual Meeting 2018

Menarini Ricerche to Present the Most Recent Pre-clinical Data About the PI3K Inhibitor MEN1611 at the AACR Annual Meeting 2018

April 14, 2018 Economie

POMEZIA, Italy, April 13, 2018 /PRNewswire/ -- Menarini Ricerche will present on the latest preclinical studies of its phosphatidylinositol 3-kinase (PI3K) class I inhibitor ...

Lees verder
Takeda and Cognition Kit Present Results from Digital Wearable Technology Study in patients with Major Depressive Disorder (MDD)

Takeda and Cognition Kit Present Results from Digital Wearable Technology Study in patients with Major Depressive Disorder (MDD)

November 17, 2017 Economie

CAMBRIDGE, England, and DEERFIELD, Illinois, Nov. 17, 2017 /PRNewswire/ -- Takeda and Cognition Kit today announced that the companies will present results from MDD-5003, a ...

Lees verder
Merck to Present New Data on MS Portfolio: Rebif, Mavenclad, and Evobrutinib at ECTRIMS 2017

Merck to Present New Data on MS Portfolio: Rebif, Mavenclad, and Evobrutinib at ECTRIMS 2017

October 19, 2017 Economie

DARMSTADT, Germany, October 18, 2017 /PRNewswire/ -- Not intended for US/UK based media Merck to Present New Data on MS Portfolio: Rebif, Mavenclad, and ...

Lees verder
Yanfeng Automotive Interiors and KOSTAL Present Smart Surfaces in 3D Glass

Yanfeng Automotive Interiors and KOSTAL Present Smart Surfaces in 3D Glass

September 12, 2017 Economie

FRANKFURT, Germany, September 12, 2017 /PRNewswire/ -- Jointly developed module celebrates its global launch at the IAA   Yanfeng Automotive Interiors (YFAI), the global ...

Lees verder
Merck to Present Data on MAVENCLAD(TM) (Cladribine Tablets) and Rebif® (interferon beta-1a) in Patients with Relapsing MS at EAN Congress 2017

Merck to Present Data on MAVENCLAD(TM) (Cladribine Tablets) and Rebif® (interferon beta-1a) in Patients with Relapsing MS at EAN Congress 2017

June 25, 2017 Economie

DARMSTADT, Germany, June 24, 2017 /PRNewswire/ -- - New data builds on company's longstanding commitment to MS  Merck, a leading science and technology company, ...

Lees verder
Nieuwe berichten
BizPress.nl